Ayana Bio
Boston · Founded 2021 · $30.3M raised
- Headquarters
- Boston
- Founded
- 2021
- Business Model
- B2B
- Website
- ayanabio.com
- Total Funding
- $30.3M
- Last Round
- $300K GrantMay 2024
- Rounds
- 2
About
Ayana Bio is a synthetic biotechnology company that uses plant cell culture technology to discover, produce, and scale plant-derived bioactive ingredients for dietary supplements, food, beverage, sports nutrition, personal care, and companion animal products. Operating out of Boston, the company partners with Ginkgo Bioworks and functions as an integrated discovery engine, laboratory, and production facility, delivering consistent, high-quality bioactive ingredients without the supply risks of traditional field agriculture.
Summary
Ayana Bio is a Biotech company based in Boston, founded in 2021. It has raised $30.3M in total across 2 rounds, most recently a $300K Grant round in May 2024. Investors include National Institutes of Health, Viking Global and Cascade Investment.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...